<SEC-DOCUMENT>0001193125-26-222953-index.html : 20260514
<SEC-HEADER>0001193125-26-222953.hdr.sgml : 20260514
<ACCEPTANCE-DATETIME>20260514090351
ACCESSION NUMBER:		0001193125-26-222953
CONFORMED SUBMISSION TYPE:	S-8 POS
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20260514
DATE AS OF CHANGE:		20260514
EFFECTIVENESS DATE:		20260514

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apellis Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001492422
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				271537290
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8 POS
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-229876
		FILM NUMBER:		26976127

	BUSINESS ADDRESS:	
		STREET 1:		100 FIFTH AVENUE
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		617-977-5700

	MAIL ADDRESS:	
		STREET 1:		100 FIFTH AVENUE
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8 POS
<SEQUENCE>1
<FILENAME>d21842ds8pos.htm
<DESCRIPTION>S-8 POS
<TEXT>
Document 1 - file: d21842ds8pos.htm

</DOCUMENT>
</SEC-DOCUMENT>